Last 1,475 GBp
Change Today +11.50 / 0.79%
Volume 7.5M
GSK On Other Exchanges
Symbol
Exchange
OTC US
New York
Xetra
London
Mexico
Frankfurt
As of 11:35 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul-Peter Tak

Head of Immunoinflammation Therapy Area Unit, GlaxoSmithKline plc
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Dr. Paul-Peter Tak serves as the Head of Immunoinflammation Therapy Area Unit at GlaxoSmithKline plc. Dr. Tak serves as a Member of Scientific Advisory Board of Index Life VI.

Corporate Headquarters*

980 Great West Road
Brentford, Middlesex TW8 9GS

United Kingdom

Phone: 44 20 8047 5000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:LN 1,474.50 GBp +11.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Indra K. Nooyi M.P.P.M.Chairman and Chief Executive Officer
Pepsico, Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.